Leucine-rich Repeat-containing 15 as a Potential Marker and Therapeutic Target in Cervical Cancer
<i>LRRC15</i> expression is a marker of poorer prognosis in patients with CC, suggesting that <i>LRRC15</i> represents a potential therapeutic strategy for CC.
Authors
- Kazuhiro Okamoto (ORCID: https://orcid.org/0000-0001-9838-2286)
- Hisashi Masuyama (ORCID: https://orcid.org/0000-0003-2589-2028)
- Eriko Eto (ORCID: https://orcid.org/0000-0002-9112-9699)
- Keiichiro Nakamura (ORCID: https://orcid.org/0000-0002-4609-5258)
- Thông Dao (ORCID: https://orcid.org/0000-0001-7043-4662)
- Thuy Ha Vu
Institutions
- Okayama University (JP)
- Hai phong University Of Medicine and Pharmacy (VN)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-11-29
- DOI
- https://doi.org/10.21873/anticanres.17877
- Primary Topic
- Clusterin in disease pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00